Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 2
2020 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Significance of concurrent use of weekly cisplatin in carbon-ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix: A propensity score-matched analysis.
Okonogi N, Wakatsuki M, Kato S, Murata H, Kiyohara H, Karasawa K, Ohno T, Tsuji H, Nakano T, Shozu M; Working Group of Gynecological Tumors. Okonogi N, et al. Cancer Med. 2020 Feb;9(4):1400-1408. doi: 10.1002/cam4.2784. Epub 2019 Dec 31. Cancer Med. 2020. PMID: 31891228 Free PMC article.
A Phase 1/2 Study of Carbon Ion Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Uterine Cervical Squamous Cell Carcinoma (Protocol 1302).
Okonogi N, Wakatsuki M, Kato S, Karasawa K, Miyasaka Y, Murata H, Nakano T, Kamada T, Shozu M; Working Group of Gynecological Tumors. Okonogi N, et al. Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):631-639. doi: 10.1016/j.ijrobp.2019.02.042. Epub 2019 Feb 27. Int J Radiat Oncol Biol Phys. 2019. PMID: 30825494 Clinical Trial.
Clinical outcomes of carbon ion radiotherapy with concurrent chemotherapy for locally advanced uterine cervical adenocarcinoma in a phase 1/2 clinical trial (Protocol 1001).
Okonogi N, Wakatsuki M, Kato S, Karasawa K, Kiyohara H, Shiba S, Kobayashi D, Nakano T, Kamada T, Shozu M; Working Group of Gynecological Tumors. Okonogi N, et al. Cancer Med. 2018 Feb;7(2):351-359. doi: 10.1002/cam4.1305. Epub 2018 Jan 17. Cancer Med. 2018. PMID: 29341491 Free PMC article. Clinical Trial.